Bioceres Crop Solutions Corp. (BIOX)
NASDAQ: BIOX · Real-Time Price · USD
0.8378
-0.1303 (-13.46%)
At close: Jan 30, 2026, 4:00 PM EST
0.9064
+0.0686 (8.19%)
After-hours: Jan 30, 2026, 4:41 PM EST
Bioceres Crop Solutions Stock Forecast
BIOX's stock price has decreased by -88.03% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts that cover Bioceres Crop Solutions stock have a consensus rating of "Buy" and an average price target of $4.33, which forecasts a 416.83% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $6.00.
Price Target: $4.33 (+416.83%)
Analyst Consensus: Buy
* Price targets were last updated on Jan 2, 2026.
Analyst Ratings
The average analyst rating for Bioceres Crop Solutions stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $2.25 → $2 | Hold | Maintains | $2.25 → $2 | +138.72% | Jan 2, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $2.5 → $2.25 | Hold | Maintains | $2.5 → $2.25 | +168.56% | Nov 14, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $8 → $5 | Strong Buy | Maintains | $8 → $5 | +496.80% | Sep 10, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $6.5 → $2.5 | Strong Buy → Hold | Downgrades | $6.5 → $2.5 | +198.40% | Sep 10, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +616.16% | Jul 15, 2025 |
Financial Forecast
Revenue This Year
327.17M
from 333.34M
Decreased by -1.85%
Revenue Next Year
431.72M
from 327.17M
Increased by 31.96%
EPS This Year
-0.30
from -0.88
EPS Next Year
0.23
from -0.30
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 351.1M | 491.2M | |
| Avg | 327.2M | 431.7M | |
| Low | 301.0M | 371.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.3% | 50.1% | |
| Avg | -1.9% | 32.0% | |
| Low | -9.7% | 13.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.17 | 0.43 | |
| Avg | -0.30 | 0.23 | |
| Low | -0.41 | 0.05 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.